CFDA Updates

January 31, 2018

China’s Grand Pharmaceutical and Canada’s Conavi Medical Align On Imaging Technology

China’s Grand  Pharmaceutical has announced that it entered into a subscription agreement with Canada’s Conavi Medical. The two companies also entered an exclusive distribution agreement for Conavi’s products. Pursuant to […]
January 31, 2018

Weekly CFDA Updates(Jan 22-29, 2018)

CFDA policies, regulation updates, QA/recall/AE, and new approvals in medical device and IVD for the week of Jan 22-29, 2018:   1. Policy: CFDA announced Comprehensive Regulatory Plan for Medical […]
January 30, 2018

2018 CFDA Changes in IVD Product Classification

On December 29th 2017, CFDA issued Circular No. 226 of 2017, redefining the attributes and categories of IV diagnostic reagent products such as allergens, FACS, immunohistochemistry and in situ hybridization. […]
January 29, 2018

CFDA Must Read—— New Guideline for Medical Device Oversea Inspection

The CFDA is putting greater emphasis on the quality system management and post-market compliance of overseas medical device manufacturers. In the past, very rarely did the national CFDA make public […]
January 26, 2018

Key Aspects to Expedite Your Medical Device’s Approval with CFDA

After a major overhaul in 2014, the CFDA “Regulations on the Supervision and Administration of Medical Devices” have been focusing on registration quality management system verification with higher requirements, compared […]